75.3 percent of patients report successful pessary treatment at five-year follow-up, with discontinuation rates decreasing over time<\/p>\n<\/h3>\n
<\/b><\/p>\n
<\/b><\/p>\n
WEDNESDAY, Feb. 24, 2021 (HealthDay News) — About three-quarters of patients with symptomatic pelvic organ prolapse (POP) report successful pessary treatment at five-year follow-up, according to a study published online Feb. 24 in Menopause<\/em>.<\/p>\n Congcong Ma, Ph.D., from the Peking Union Medical College Hospital in Beijing, and colleagues conducted a prospective observational study involving 312 women with symptomatic POP who received pessary treatment between November 2013 and July 2015. Patients were initially fitted with a ring pessary with support, and those who failed were fitted with a Gellhorn pessary. For five years, 265 patients with successful pessary fitting were followed.<\/p>\n The researchers found that 180 of 239 patients continued pessary use after five years (75.3 percent continuation rate) and 26 were lost to follow-up. Over time, there was a decrease in discontinuation rates, from 8.7 to 2.7 percent at one and five years, respectively. Potential discontinuation risk factors included total vaginal length <7.5 cm, improvement in Urinary Impact Questionnaire-7 scores <50 percent at three months, and incapability of self-care (odds ratios, 2.7, 2.1, and 2.6, respectively).<\/p>\n “The vaginal pessary is an effective treatment in patients with symptomatic POP, with a high continuation rate and minor complications,” the authors write.<\/p>\n Abstract\/Full Text (subscription or payment may be required)<\/a><\/p>\n <\/i><\/p>\n